/ 100
Aurobindo Pharma Limited (AUROPHARMA) — Technical Setup
₹1,734 +2.60% Uptrend Normal Volatility Strong bullish
Summary
Aurobindo Pharma Limited is in a uptrend on the daily chart, with the weekly trend bullish and the monthly trend bullish. RSI(14) is 63.5, MACD is above its signal line, ADX reads 22. The stock trades 24.0% above its 200-day average and 0.0% below its 52-week high. Volume in the latest session was 1.6× its 20-day average. Over three months it has outperformed the Nifty 50 by 15.0 percentage points. Nearest support is ₹1,704.00, with no swing resistance overhead. Its technical score is 94/100 (strong bullish).
🧮 How the 94/100 is built
Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.
- Close above 20-day EMA (4.10)3/3
- 20-day EMA above 50-day EMA3/3
- 50-day EMA above 200-day EMA3/3
- Close above 200-day SMA (23.99)3/3
- SuperTrend (10,3) pointing up3/3
- ADX ≥ 20 with +DI above −DI (trend has strength) (21.65)3/3
- Weekly trend up (above a rising 30-week average)2/2
- RSI(14) in the bullish zone (55-70 best) (63.54)6/6
- MACD line above its signal line4/4
- MACD line above zero (20.28)3/3
- 12-day rate of change positive (5.21)3/3
- Stochastic %K above %D2/2
- Outperforming the Nifty 50 over 3 months (15.03)2/2
- On-balance volume rising over 20 sessions5/5
- Chaikin Money Flow (20) positive (0.35)5/5
- More volume on up days than down days (20 sessions) (1.99)5/5
- Close above 20-day VWAP (4.20)5/5
- Daily range (ATR%) contained — ≤2.5% scores full (2.25)6/6
- Price in the upper half of its Bollinger Bands (1.04)3/5
- Shallow drawdown from the 52-week high (0.00)5/5
- Volatility contracting (20-day volatility below its 6-month median) (67.20)0/4
- Room to the next resistance (≥8% scores full)5/5
- Support close below (a tight, definable stop) (1.73)5/5
- Broke above a 20-day high in the last 5 sessions5/5
- Within 5% of the 52-week high (0.00)5/5
🧭 Regime: Uptrend
Normal Volatility — Bollinger width is in the 30th percentile of the last six months.
Suits: Trend-following, selectively. The trend is up but not forceful — favour entries near support and keep stops below the 50-day EMA.
Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.
Opens the AI Backtester with the 20/50 EMA Crossover rules for AUROPHARMA — 20-day ema crosses above the 50-day ema.
🕰️ Multi-timeframe
| Timeframe | Trend | RSI (14) | MACD hist. |
|---|---|---|---|
| Monthly | ▲ Bullish | 77.65 | 58.03 |
| Weekly | ▲ Bullish | 74.11 | 5.29 |
| Daily | ▲ Bullish | 63.54 | 1.41 |
Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: Bullish, weekly ADX 40.99.
📶 Volume & VWAP
VWAPs are computed from daily bars (typical price × volume), not intraday ticks.
💪 Relative strength
AUROPHARMA ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming. The RS line is at a 52-week high.
🧱 Support & resistance
Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.
| Level | Price | Distance | Touches |
|---|---|---|---|
| Close | ₹1,734 | — | |
| Support | ₹1,704.00 | −1.7% | 3 |
| Support | ₹1,636.80 | −5.6% | 1 |
| Support | ₹1,591.80 | −8.2% | 2 |
| Support | ₹1,543.40 | −11.0% | 2 |
52-week range: ₹1,067 – ₹1,734 (+0.00% from the high).
🌀 Fibonacci
Measuring the up-swing from ₹1,255.40 (2026-03-24) to ₹1,734.00 (2026-09-18). Price has retraced 0.0% of it.
| Ratio | Price | Distance | |
|---|---|---|---|
| 23.6% retracement | ₹1,621.05 | -6.5% | S/R confluence nearest |
| 38.2% retracement | ₹1,551.17 | -10.5% | S/R confluence |
| 50.0% retracement | ₹1,494.70 | -13.8% | |
| 61.8% retracement | ₹1,438.23 | -17.1% | |
| 78.6% retracement | ₹1,357.82 | -21.7% | |
| 127.2% extension | ₹1,864.18 | +7.5% | |
| 161.8% extension | ₹2,029.77 | +17.1% | |
| 200.0% extension | ₹2,212.60 | +27.6% |
🕯️ Candlesticks (last 5 sessions)
- Bullish Marubozu 2026-09-17 bullish Moderate · 50
Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.
↗️ Divergences
No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.
📐 Chart pattern
- Ascending Channel dailyforming
- Double Bottom weeklybreakout up · target ₹1,733
✅ Screens AUROPHARMA passes today
| Stock | Close | Chg | Score | Trend regime | RS rating (1-99) |
|---|---|---|---|---|---|
| AAREYDRUGSAarey Drugs & Pharmaceuticals Limited | ₹102.13 | +0.40% | 85 | Strong Uptrend | 86.00 |
| ACUTAASAcutaas Chemicals Limited | ₹3,440 | +3.78% | 85 | Uptrend | 93.00 |
| KOPRANKopran Limited | ₹277.60 | +3.35% | 85 | Strong Uptrend | 96.00 |
| BAFNAPHBafna Pharmaceuticals Limited | ₹317.20 | +1.99% | 84 | Strong Uptrend | 98.00 |
| KILITCHKilitch Drugs (India) Limited | ₹191.45 | +1.47% | 84 | Uptrend | 63.00 |
| CAPLIPOINTCaplin Point Laboratories Limited | ₹2,749 | +5.85% | 83 | Uptrend | 83.00 |
| GLANDGland Pharma Limited | ₹2,962 | +1.86% | 83 | Strong Uptrend | 91.00 |
| JUBLPHARMAJubilant Pharmova Limited | ₹1,065 | +5.27% | 80 | Strong Uptrend | 64.00 |
| STARStrides Pharma Science Limited | ₹1,220 | +1.63% | 80 | Strong Uptrend | 81.00 |
| ZIMLABZim Laboratories Limited | ₹135.51 | -1.75% | 80 | Strong Uptrend | 92.00 |
⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.
